Literature DB >> 12064827

The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis.

Olivier Ethgen1, Kristijan H Kahler, Sheldon X Kong, Jean-Yves Reginster, Frederick Wolfe.   

Abstract

OBJECTIVE: In today's cost conscious environment, health services researchers are consistently trying to find ways to predict future health care resource utilization (HCRU) and its associated costs. We evaluated the impact of health related quality of life (HRQL) on future HCRU in patients with arthritis.
METHODS: A total of 642 patients with rheumatoid arthritis (RA) and 395 patients with osteoarthritis (OA) completed at least 2 and as many as 6 consecutive surveys at 6 mo intervals. Information collected included demographics, HRQL questionnaires [Medical Outcome Study Short Form 36 (SF-36), Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), and the Stanford Health Assessment Questionnaire (HAQ)], and HCRU over the previous 6 months. Longitudinal data analysis was perfomed to assess the effect of HRQL on future HCRU.
RESULTS: Statistically significant associations between HCRU and HRQL variables were noted. Higher rates of HCRU were found in those in the worst quarter compared with those in the best quarter of HRQL. With the HAQ, OA and RA patients in the worst quarter reported a 199% (p < 0.05) and 48% (p < 0.05) increase in rheumatologist visits, respectively. With the WOMAC Function, increases were as high as 196% (p < 0.05) in rheumatologist visits for patients with OA. Patients with RA with a high level of HRQL as measured by the SF-36 (physical component score) reported a decrease of 31% (p < 0.01) in general practitioner visits and a decrease of 52% (p < 0.01) in hospitalization (mental component score).
CONCLUSION: These findings suggest that HRQL may be used to predict future health care consumption. Such an approach may lead to a more efficient allocation of resources by providing useful information to health care providers and health care decision makers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064827

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  25 in total

1.  Health status attributes of older African-American adults with hearing loss.

Authors:  Kenneth C Pugh
Journal:  J Natl Med Assoc       Date:  2004-06       Impact factor: 1.798

2.  Occupational work and quality of life in osteoarthritis patients.

Authors:  Elzbieta Łastowiecka; Joanna Bugajska; Andrzej Najmiec; Maria Rell-Bakalarska; Irena Bownik; Anna Jedryka-Góral
Journal:  Rheumatol Int       Date:  2006-11-09       Impact factor: 2.631

3.  Quality of life assessments with SF 36 in different musculoskeletal diseases.

Authors:  Figen Yilmaz; Fusun Sahin; Ernur Ergoz; Emel Deniz; Cem Ercalik; Serap Dalgic Yucel; Banu Kuran
Journal:  Clin Rheumatol       Date:  2007-09-13       Impact factor: 2.980

4.  EQ-5D as a predictor of mortality and hospitalization in elderly people.

Authors:  Giulia Cavrini; Serena Broccoli; Aurora Puccini; Marco Zoli
Journal:  Qual Life Res       Date:  2011-06-09       Impact factor: 4.147

5.  Use of OROS® hydromorphone in the treatment of osteoarthritis and osteoporosis: A pooled analysis of three non-interventional studies focusing on different starting doses.

Authors:  Johann D Ringe; Susanne Schäfer; Antonie M Wimmer; Thorsten Giesecke
Journal:  Wien Klin Wochenschr       Date:  2011-11-04       Impact factor: 1.704

6.  Impact of knee osteoarthritis on health care resource utilization in a US population-based national sample.

Authors:  Elizabeth A Wright; Jeffrey N Katz; Miriam G Cisternas; Courtenay L Kessler; Aubrey Wagenseller; Elena Losina
Journal:  Med Care       Date:  2010-09       Impact factor: 2.983

7.  Impact of musculoskeletal disorders on quality of life: an inception cohort study.

Authors:  C H Roux; F Guillemin; S Boini; F Longuetaud; N Arnault; S Hercberg; S Briançon
Journal:  Ann Rheum Dis       Date:  2004-12-02       Impact factor: 19.103

8.  Ambulatory visit utilization in a national, population-based sample of adults with osteoarthritis.

Authors:  Miriam G Cisternas; Edward Yelin; Jeffrey N Katz; Daniel H Solomon; Elizabeth A Wright; Elena Losina
Journal:  Arthritis Rheum       Date:  2009-12-15

9.  A randomized, controlled study to evaluate the efficacy of intra-articular, autologous adipose tissue injections for the treatment of mild-to-moderate knee osteoarthritis compared to hyaluronic acid: a study protocol.

Authors:  Ian A Jones; Melissa Wilson; Ryan Togashi; Bo Han; Austin K Mircheff; C Thomas Vangsness
Journal:  BMC Musculoskelet Disord       Date:  2018-10-24       Impact factor: 2.362

Review 10.  Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.

Authors:  Katherine A Lyseng-Williamson; Rachel H Foster
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.